1T0C image
Deposition Date 2004-04-08
Release Date 2005-08-16
Last Version Date 2024-05-22
Entry Detail
PDB ID:
1T0C
Title:
Solution Structure of Human Proinsulin C-Peptide
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Conformers Calculated:
800
Conformers Submitted:
30
Selection Criteria:
structures with the lowest energy
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Insulin
Gene (Uniprot):INS
Chain IDs:A
Chain Length:31
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Solution structure of human proinsulin C-peptide
Febs J. 272 4284 4293 (2005)
PMID: 16098208 DOI: 10.1111/j.1742-4658.2005.04843.x

Abstact

The C-peptide of proinsulin is important for the biosynthesis of insulin, but has been considered for a long time to be biologically inert. Recent studies in diabetic patients have stimulated a new debate about its possible regulatory role, suggesting that it is a hormonally active peptide. We describe structural studies of the C-peptide using 2D NMR spectroscopy. In aqueous solution, the NOE patterns and chemical shifts indicate that the ensemble is a nonrandom structure and contains substructures with defined local conformations. These are more clearly visible in 50% H2O/50% 2,2,2-trifluoroethanol. The N-terminal region (residues 2-5) forms a type I beta-turn, whereas the C-terminal region (residues 27-31) presents the most well-defined structure of the whole molecule including a type III'beta-turn. The C-terminal pentapeptide (EGSLQ) has been suggested to be responsible for chiral interactions with an as yet uncharacterized, probably a G-protein-coupled, receptor. The three central regions of the molecule (residues 9-12, 15-18 and 22-25) show tendencies to form beta-bends. We propose that the structure described here for the C-terminal pentapeptide is consistent with the previously postulated CA knuckle, believed to represent the active site of the C-peptide of human proinsulin.

Legend

Protein

Chemical

Disease

Primary Citation of related structures